Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tailored breathing support may protect lungs during robot prostate surgery

NCT ID NCT06540794

Disease control Sponsor: Istanbul University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This trial tests whether a personalized ventilation strategy, guided by electrical impedance tomography (EIT), can reduce lung complications in men undergoing robot-assisted prostate removal. During this surgery, the abdomen is inflated with gas and the patient is tilted head-down, which can compress the lungs. The study compares standard ventilation with a method that adjusts airway pressure to minimize stress on the lungs, using EIT to monitor lung function in real time.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
personalized positive end-expiratory pressure (PEEP) guided by electrical impedance tomography
What this could lead to
If successful, this approach could reduce lung complications during and after robot-assisted prostate surgery.
What could go wrong
This is a small, early-stage trial with 42 participants, so results may not apply broadly. The technique requires specialized equipment and expertise.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

42 people

The number who actually took part.

Started

Aug 2024

Finished

Oct 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Up to 80 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ASA score of I-II-III according to the American Society of Anesthesiologists (ASA) physical status classification system * Surgery duration is expected to be longer than 2 hours Exclusion Criteria: * Patients who underwent surgery requiring mechanical ventilation for more than 1 hour within 2 weeks before the operation * Patients with a body mass index over 35 * Patients with large bullae or pneumothorax, those currently receiving oxygen support, those with severe respiratory disease * Patients with severe heart failure classified as NYHA class III-IV by the New York Heart Association (NYHA), those with a pacemaker or cardiac defibrillator implant * Patients with progressive neuromuscular disease * Patients who refused to participate in the study were excluded.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung-protective ventilation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung-protective ventilation Postoperative pulmonary complications Prostate cancer

Contacts and locations

Locations

  • Istanbul University- Cerrahpasa, Cerrahpasa Faculty of Medicine Department of Anesthesiology and Reanimation

    Istanbul, 34303, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.